References
- Singh BN, Hollenberg NK, Poole-Wilson PA, Robertson J IS. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. Journal of Hypertens 1992; 10: 301–316
- Mc Innes GT, Yeo WW, Ramsay Le, Moser M. Cardiotoxicity and diuretics: much speculation - little substance. Journal of Hypertens 1992; 10: 317–335
- Veterans Administration Co-Operative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213: 1143–1152
- Report by the Management Committee. The Australian Therapeutic Trial in mild hypertension. Lancet 1980; i: 1261–1267
- Hypertension Detection and Follow-Up Program Co-Operative Group. Five year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality of person s with high blood pressure, including mild hypertension. JAMA 1979; 252: 2562–2571
- Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality rate. JAMA 1982; 245: 1465–1477
- Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291: 97–104
- Wilhelmsen L, Berglunk G, Elmfeldt D, Fitzsimons T, Holtzgreve H, Hornquist PE, et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987
- Wikstrand J, Warnold I, Olssson G, Tuomilehto J, Elmfeldt D, Berglund G. Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study. JAMA 1988; 259: 76–82
- Collins R, Peto R, Macmahon S, Bebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease Part 2, short term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–838
- Thijs L, Fagard R, Lijnen P, Staessen J, Van Hoof R, Amery A. A meta-analysis of outcome trials in elderly hypertension. J Hypertens 1992; 10: 1103–1109
- Beard K, Bulpitt C, Masue-Taylor H, Omalley H, Sever D, Webb S. Management of elderly patients with sustained hypertension. BMJ 1992; 304: 412–416
- Shep Co-Operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–3264
- Dahlof B, Lindholm L, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281–1285
- MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405–413
- Kaplan NM. Problems with the use of diuretics in the treatment of hypertension. Am J Nephrol 1986; 6: 1–5
- McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987; 308: 787–792
- Kannel WB, Cupples LA, Agostino RB, Stokes J. Hypertension, antihypertensive treatment and sudden coronary death: the Framingham Study. Hypertension 1988; 11(Suppl II)II–50
- MRC Working party on mild to moderate hypertension: Ventricular extrasystoles during thiazide treatment substudy of MRC mild hypertension trial. BMJ 1983; 287: 1249–1253
- Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo Study. Am J Med 1980; 69: 725–732
- Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868–873
- Ferrannini E, Buzzigoli G, Bonadonna R, Antonielta AM, Oleggini M, Graziades L, Pedvinelli R, Brandi L, Bevilacque S. Insulin resistance in essential hypertension. New Engl J Med 1987; 317: 350–357
- Lithele HO. Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diabetes Care 1991; 14: 203–209
- Warren JH, Lattell L MB, Valsania P, Christlieb AR, Krolewski AS. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Int med 1991; 151: 1350–1356
- Kaplan NM. Systolic Hypertension in the Elderly Program (SHEP) and Swedish Trial in Old Patients with Hypertension (STOP). Am J Hypertens 1992; 5: 331–334
- Weinberger MH. Diuretics and their side effects dilemma in the treatment of. hypertension 1988; 11(Suppl 11)II16–II20
- MRC Working Party. Comparison of the antihypertensive efficacy and adverse reaction to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: substudies and the MRC trials of treatment of mild hypertension. J Clin Pharmacol 1987; 27: 271–277
- Weinberger MH. Angiotensin converting enzyme inhibitors enhance the antihypertensive efficacy of diuretics and blunt or prevent adverse metabolic effects. J Cardiovas Pharmacol 1989; 13(Suppl 3)S1–4
- Dahlof B, Pennert K, Hansson L. Reversal of Left Ventricular Hypertension in Hypertensive Patients: A meta-analysis of 109 Treatment Studies. Am J Hypertens 1992; 95–110
- Dahloff B, Hansson L. Regression of Left Ventricular Hypertension in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide. J Hypertens 1992; 10: 1513–1524